1. Home
  2. CHH vs RGEN Comparison

CHH vs RGEN Comparison

Compare CHH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHH
  • RGEN
  • Stock Information
  • Founded
  • CHH 1939
  • RGEN 1981
  • Country
  • CHH United States
  • RGEN United States
  • Employees
  • CHH N/A
  • RGEN N/A
  • Industry
  • CHH Hotels/Resorts
  • RGEN Medical/Dental Instruments
  • Sector
  • CHH Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • CHH Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CHH 6.8B
  • RGEN 7.1B
  • IPO Year
  • CHH 1997
  • RGEN N/A
  • Fundamental
  • Price
  • CHH $123.95
  • RGEN $130.00
  • Analyst Decision
  • CHH Hold
  • RGEN Buy
  • Analyst Count
  • CHH 14
  • RGEN 12
  • Target Price
  • CHH $139.07
  • RGEN $175.56
  • AVG Volume (30 Days)
  • CHH 449.4K
  • RGEN 951.5K
  • Earning Date
  • CHH 05-08-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • CHH 0.93%
  • RGEN N/A
  • EPS Growth
  • CHH 22.29
  • RGEN N/A
  • EPS
  • CHH 6.20
  • RGEN N/A
  • Revenue
  • CHH $791,189,000.00
  • RGEN $634,439,000.00
  • Revenue This Year
  • CHH $104.25
  • RGEN $12.29
  • Revenue Next Year
  • CHH $3.77
  • RGEN $15.20
  • P/E Ratio
  • CHH $19.99
  • RGEN N/A
  • Revenue Growth
  • CHH 4.10
  • RGEN 0.33
  • 52 Week Low
  • CHH $109.22
  • RGEN $102.97
  • 52 Week High
  • CHH $157.86
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CHH 41.69
  • RGEN 48.60
  • Support Level
  • CHH $122.55
  • RGEN $105.06
  • Resistance Level
  • CHH $129.97
  • RGEN $135.81
  • Average True Range (ATR)
  • CHH 5.28
  • RGEN 9.95
  • MACD
  • CHH 0.27
  • RGEN 1.83
  • Stochastic Oscillator
  • CHH 42.35
  • RGEN 82.31

About CHH Choice Hotels International Inc.

As of Dec. 31, 2023, Choice Hotels operated 633,000 rooms across 15 brands addressing the economy and midscale segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total domestic rooms), while Ascend and Cambria (7% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added around 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 79% of total rooms in 2023.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: